Mary Slatter | Trustee

Pioneering Director

Mary qualified from Bristol University in 1987. Following training in General Paediatrics she spent 1994 to 1998 working with her family at a Mission hospital in the Democratic Republic of Congo. On their return they moved to Newcastle upon Tyne where she took up a post on the Paediatric Haematopoietic stem cell transplant (HSCT) unit. Mary has been the Clinical Programme Director since 2010 and led the unit through successful Joint Accreditation Committee-ISCT (Europe) & EBMT (JACIE) accreditation in 2014. She coordinates the day to day care of the patients, planning each child’s treatment programme including the identification and work-up of stem cell donors and the writing of individual protocols. Her research focuses on improving techniques for HSCT in Primary Immunodeficiency. She has pioneered the use of treosulfan in conditioning these patients and the recent use of TCR alpha/beta/CD19 depletion using a parent when a patient has no matched donor. She is interested in the longterm follow up of children post transplantation. She contributes significantly to the clinical research output from the unit in terms of scientific presentations and publications and is an active member of the Inborn Errors working party of EBMT and the UK Paediatric HSCT group.